Get the Stockscreener App
907.99
1.45%
-13.39
After Hours:
907.99
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Mckesson Corp stock is traded at $907.99, with a volume of 683.16K.
It is down -1.45% in the last 24 hours and up +9.34% over the past month.
McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
See More
Previous Close:
$921.38
Open:
$911.15
24h Volume:
683.16K
Relative Volume:
0.69
Market Cap:
$105.86B
Revenue:
$403.43B
Net Income/Loss:
$5.10B
P/E Ratio:
23.61
EPS:
38.4657
Net Cash Flow:
$5.41B
1W Performance:
+1.63%
1M Performance:
+9.34%
6M Performance:
-7.23%
1Y Performance:
+31.32%
1-Day Range:
$905.10
$921.09
1-Week Range:
$876.48
$929.95
52-Week Range:
$682.35
$999.00
Mckesson Corp Stock (MCK) Company Profile
Name
Mckesson Corp
Sector
Industry
Phone
972-446-4800
Address
6555 STATE HIGHWAY 161, IRVING, TX
Compare MCK vs COR, CAH, HSIC, AHG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MCK
Mckesson Corp
|
907.99 | 97.79B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
330.95 | 60.05B | 328.68B | 2.55B | 1.56B | 13.03 |
CAH
Cardinal Health Inc
|
247.18 | 53.13B | 250.74B | 1.55B | 4.39B | 6.5398 |
HSIC
Henry Schein Inc
|
89.81 | 9.86B | 13.38B | 418.00M | 391.00M | 3.3112 |
AHG
Akso Health Group Adr
|
0.848 | 873.84M | 14.85M | -136.07M | 7.25M | -0.4726 |
Mckesson Corp Stock (MCK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Barclays | Overweight |
| Dec-04-24 | Resumed | Mizuho | Neutral |
| Nov-07-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-24-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Sep-05-24 | Reiterated | Leerink Partners | Outperform |
| Aug-08-24 | Reiterated | Mizuho | Neutral |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-14-23 | Initiated | Wells Fargo | Equal Weight |
| Mar-31-23 | Initiated | Citigroup | Buy |
| Aug-22-22 | Resumed | Morgan Stanley | Overweight |
| Jul-06-22 | Downgrade | Argus | Buy → Hold |
| Jun-07-22 | Upgrade | Deutsche Bank | Hold → Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Feb-04-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jan-07-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Nov-02-21 | Reiterated | Barclays | Overweight |
| Nov-02-21 | Reiterated | BofA Securities | Buy |
| Nov-02-21 | Reiterated | Evercore ISI | Outperform |
| Nov-02-21 | Reiterated | Jefferies | Buy |
| Mar-30-21 | Upgrade | Argus | Hold → Buy |
| Nov-02-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-04-20 | Upgrade | Deutsche Bank | Hold → Buy |
| May-22-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| May-15-20 | Upgrade | UBS | Neutral → Buy |
| Apr-23-20 | Resumed | Credit Suisse | Neutral |
| Mar-18-20 | Upgrade | Goldman | Neutral → Buy |
| Mar-13-20 | Upgrade | Guggenheim | Neutral → Buy |
| Feb-07-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jan-10-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-12-19 | Initiated | Deutsche Bank | Hold |
| Aug-05-19 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jul-22-19 | Initiated | Guggenheim | Neutral |
| Jan-17-19 | Initiated | UBS | Neutral |
| Oct-26-18 | Reiterated | Barclays | Equal Weight |
| Jul-20-18 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-29-18 | Reiterated | Leerink Partners | Mkt Perform |
| Mar-08-18 | Initiated | Barclays | Equal Weight |
| Feb-27-18 | Resumed | BofA/Merrill | Buy |
| Feb-02-18 | Reiterated | Mizuho | Neutral |
| Jan-24-18 | Upgrade | Jefferies | Hold → Buy |
View All
Mckesson Corp Stock (MCK) Latest News
McKesson Corp's negligence caused a data breach, a new class action lawsuit claims - claimdepot.com
Novocure Reports Patient Data Exposure in Cybersecurity Incident - Zacks Investment Research
McKesson Stock (MCK) Opinions on Recent Data Leak and Market Dynamics - Quiver Quantitative
Mckesson Stock Price Forecast. Should You Buy MCK? - StockInvest.us
McKesson Owns Antitrust Claims, Not Rite Aid, Judge Finds - law360.com
McKesson Corp. stock underperforms Friday when compared to competitors - MarketWatch
McKesson Corp (MCK) Stock Price, Quote, News & History - Benzinga
McKesson Data Breach: Investigation Ongoing - claimdepot.com
McKesson Stock: Is MCK Outperforming the Healthcare Sector? - Barchart.com
Mckesson Corporation (MCK) News, Articles, Events & Latest Updates - Stocktwits
McKesson Corp. stock outperforms competitors on strong trading day - MarketWatch
Mckesson Corp Stock (MCK) Moved Up by 3.13% on Sep 1: Key Drivers Unveiled - TradingKey
McKesson data breach exposes prescribing physicians and their patients to fallout from a third-party attack - Medical Economics
ShinyHunters Threatens to Leak Millions of McKesson Records - BankInfoSecurity
McKesson Hit by Cyberattack Affecting 284M Patient Records - Medical Device and Diagnostic industry
McKesson Okta and Cloud Services Breach Analysis: ShinyHunters Vishing Attack Leads to Major Healthcare Data Exfiltration - Rescana
Mckesson CorpDiscovers Cybersecurity Incident Affecting Information Systems On August 25, 2026SEC Filing - TradingView
8 things to know: Drug distribution giant to buy Maryland firm for $2.25B - The Business Journals
McKesson Corporation (MCK) Discloses Cybersecurity Incident in S - GuruFocus
Amid layoffs including at Rx Savings in OP, parent McKesson plans $2.25B acquisition - The Business Journals
Here’s How Much You Would Have Made Owning McKesson Stock In The Last 10 Years - Benzinga
McKesson to acquire Precision Medicine Group - chaindrugreview.com
McKesson stock jumps on $2.25B Precision Medicine deal - Investing.com
Mckesson Corp Stock (MCK) Moved Up by 3.13% on Aug 21: A Full Analysis - TradingKey
McKesson gains as investors lean on strong earnings backdrop and recent guidance lift - Quiver Quantitative
McKesson (MCK) Stock May Trade At A Discount As Cash Flow Holds Up - Yahoo Finance
McKesson Corp. stock outperforms competitors despite losses on the day - MarketWatch
LLY4104766 Bond Profile — Key Metrics - TradingView
McKesson Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
MCKESSON CORP : RBC INITIATES COVERAGE WITH SECTOR PERFORM RATING; TARGET PRICE $845 - Bitget
Winners And Losers Of Q2: McKesson (NYSE:MCK) Vs The Rest Of The Healthcare Providers & Services Stocks - Yahoo Finance
McKesson Corp. stock underperforms Monday when compared to competitors - MarketWatch
McKesson director Bradley Lerman sells $268,589 in shares By Investing.com - Investing.com Australia
McKesson director Bradley Lerman sells $268,589 in shares - Investing.com
Summit Global Investments Invests $1.16 Million in McKesson Corporation $MCK - MarketBeat
BIP Wealth LLC Invests $1.75 Million in McKesson Corporation $MCK - MarketBeat
MCK|Mckesson Corp|Price:869.000|Chg%:+11.760 - TradingKey
McKesson Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Insight Wealth Strategies LLC Trims Holdings in McKesson Corporation $MCK - MarketBeat
BARLOW WEALTH PARTNERS, LLC's McKesson Corp(MCK) Holding History - GuruFocus
McKesson Corporation (MCK.F) Stock Price, News, Quote & History - Yahoo! Finance Canada
Continuum Advisory, LLC's McKesson Corp(MCK) Holding History - GuruFocus
Wedge Capital Management L L P NC Has $29.42 Million Position in McKesson Corporation $MCK - MarketBeat
McKesson Corporation (MCK) latest stock news and headlines - uk.finance.yahoo.com
What Does McKesson’s (NYSE:MCK) $105B Quarter Mean for S&P 500 Investors? - Kalkine Media
McKesson Corp (MCK) Director Bradley Lerman Sells 301 Shares, Re - GuruFocus
McKesson (NYSE:MCK) Director Sells $268,591.33 in Stock - MarketBeat
McKesson (NYSE:MCK) Given New $933.00 Price Target at Wells Fargo & Company - MarketBeat
Wells Fargo raises McKesson stock price target on earnings outlook By Investing.com - Investing.com Australia
Wells Fargo raises McKesson stock price target on earnings outlook - Investing.com
Handelsbanken Fonder AB Cuts Stock Holdings in McKesson Corporation $MCK - MarketBeat
Mckesson Corp Stock (MCK) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):